Nursing Standard

Search query:

Filter by section

Filter by keyword

Filter by author

Filter by date

Results 1 - 10 of 10 Search Tips

Nursing support during treatment of multiple myeloma with proteasome inhibitors

05 July 2018

Cancer Nursing Practice

evidence and practice

In the past two years proteasome inhibitors have risen in prominence reflecting the recent approval of two new agents, carfilzomib and ixazomib. This means there are...

Practical experience with rituximab subcutaneous

08 October 2015

Cancer Nursing Practice

CPD

Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has...

An overview of non-Hodgkin’s lymphoma

11 February 2014

Cancer Nursing Practice

CPD

Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoproliferative malignancies with differing patterns of behaviour and responses to treatment. Chemotherapy,...

A screening tool to identify frailty in older people with lymphoma and help assess treatment and social support needs

30 May 2018

Cancer Nursing Practice

frailty tool

By 2020, two million people aged 65 and over will be living with a cancer diagnosis, and about 14,000 people are diagnosed with lymphoma each year. Assessment...

Patient concerns after haematopoietic stem cell transplantation: an evaluation

16 February 2024

Cancer Nursing Practice

evidence and practice

As survival rates among patients receiving haematopoietic stem cell transplantation (HSCT) improve, there is increased recognition of patients’ long-term needs. In...

Role of clinical nurse specialists in supporting people with chronic cancer to develop expertise in their condition

09 October 2023

Cancer Nursing Practice

Chronic cancers

Background The lifting of the coronavirus disease 2019 (COVID-19) pandemic restrictions in the UK has meant a near-full return to normal life for the general...

Chimeric antigen receptor (CAR) T-cell therapy: an overview for nurses

09 September 2024

Nursing Standard

Peer-reviewed articles

Chimeric antigen receptor (CAR) T-cell therapy is a relatively new and innovative immunotherapy for haemato-oncological diseases. In the UK, CAR T-cell therapy can...

Acute promyelocytic leukaemia: reviewing outcomes of induction treatment with arsenic trioxide and retinoic acid

07 February 2022

Cancer Nursing Practice

Cancer treatments

Acute promyelocytic leukaemia (APL) is a rare subtype of acute myeloid leukaemia with high mortality rates. Chemotherapy-based regimens have demonstrated...

Investigating overall quality of life in patients with diffuse large B-cell lymphoma undergoing CAR T-cell therapy

21 May 2024

Cancer Nursing Practice

evidence and practice

Background Some adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) are eligible for chimeric antigen receptor T-cell (CAR T-cell) therapy....

Continuing professional development: lymphoma in primary care

07 May 2019

Primary Health Care

blood cancer

Lymphoma encompasses a heterogeneous group of haematological malignancies that require complex management. Patients with lymphoma experience a wide range of...

06 November 2024 / Vol 39 issue 11

TABLE OF CONTENTS

DIGITAL EDITION

SUBSCRIBE

5 Most Read Articles
Journals
Other RCNi websites